Next Article in Journal
Gene Transactivation and Transrepression in MYC-Driven Cancers
Next Article in Special Issue
Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial–Mesenchymal State in Cancer Cells
Previous Article in Journal
The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections
Previous Article in Special Issue
Mammalian Homologue NME3 of DYNAMO1 Regulates Peroxisome Division
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 7
10.3390/ijms22073457
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing

by
Shalu Sharma
1,2,
Antara Sengupta
1,2 and
Shantanu Chowdhury
1,2,3,*
1
Integrative and Functional Biology Unit, CSIR-Institute of Genomics and Integrative Biology, Mathura Road, New Delhi 110025, India
2
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
3
GNR Knowledge Centre for Genome and Informatics, CSIR-Institute of Genomics and Integrative Biology, Mathura Road, New Delhi 110025, India
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(7), 3457; https://doi.org/10.3390/ijms22073457
Submission received: 22 January 2021 / Revised: 15 February 2021 / Accepted: 17 February 2021 / Published: 27 March 2021
(This article belongs to the Special Issue Selected Papers from the 11th International Conference on the NME/NDPK/NM23/AWD Gene Family (NME 2019))
Browse Figures
Versions Notes

Abstract

:
The metastasis suppressor function of NM23 proteins is widely understood. Multiple enzymatic activities of NM23 proteins have also been identified. However, relatively less known interesting aspects are being revealed from recent developments that corroborate the telomeric interactions of NM23 proteins. Telomeres are known to regulate essential physiological events such as metastasis, ageing, and cellular differentiation via inter-connected signalling pathways. Here, we review the literature on the association of NM23 proteins with telomeres or telomere-related factors, and discuss the potential implications of emerging telomeric functions of NM23 proteins. Further understanding of these aspects might be instrumental in better understanding the metastasis suppressor functions of NM23 proteins.

1. Introduction

The Non-metastasis 23/Nucleoside diphosphate kinase NM23/NDPK protein family contributes to several cellular pathways owing to their interaction with multiple effector proteins and several known enzymatic functions of the NM23 proteins. This multifunctional family of proteins (10 in humans) is broadly divided into two groups based on their identity (Group I: NM23H1-H4, 58–88%; Group II: more divergent members, 22–44%). NM23-H1 and H2, the cytoplasmic/nuclear localizing proteins, and NM23-H4, reported mostly as mitochondrial, are amongst the most studied members of the family of proteins. These proteins have previously been extensively reviewed [1,2]. The combination of nucleoside diphosphatase kinase activity, histidine protein kinase activity, DNA binding, cell motility suppression, and transcription regulatory functions has motivated the continuous exploration of NM23/NDPK proteins and their role in cell physiology [3]. In mammalian systems, this protein-family has been associated with metastasis suppression in cancers, and they are therefore commonly known as “non-metastatic” proteins [4]. Despite a large body of work, molecular mechanisms involved in the metastasis suppressor function of the NM23 family of proteins continue to be of interest.
One of the lesser studied yet relatively direct links with cancer initiation, progression and metastasis comes from the association of NM23 proteins with chromosome ends or telomeres, and telomere binding proteins (telosome/shelterin complex) [5]. Evidence showing the association of NM23 proteins with telomeres and telosome suggests involvement of NM23 proteins in telomere maintenance. Additionally, evidence suggests the interplay of telomeres, NM23 proteins and mitochondrial dysfunction in ageing. With these in mind, here we discuss the emerging literature on direct and/or indirect functions of NM23 proteins related to telomeres and telomere-associated proteins, with particular emphasis on the role of these mechanisms in cancer and ageing.

2. Direct Interaction of NM23 Proteins with Telomeres and Telomere-Binding Proteins

2.1. NM23 Proteins Bind with the Telomeric DNA Sequence In Vitro

The first evidence of NM23 proteins interacting with the telomeric sequence came from Nosaka et al., 1998 [6]. Thirty-six -mer single and double-stranded oligonucleotides comprising telomeric repeats (TTAGGG)6 were incubated with Glutathione S-transferase (GST)-tagged recombinant NM23-H1 or H2. Only NM23-H2 had binding affinity for the telomeric sequence, but not NM23-H1. NM23-H2 was found to bind with the single-stranded, but not the double-stranded telomeric sequence in vitro. The authors further tested the specificity of the binding of NM23-H2 to the telomeric sequence and found that NM23-H2 associated with both (TTAGAG)6 and (TTGGGG)6, but not the (ATAGGG)6 sequence.
The NM23-H2 homologue in zebrafish Danio rerio known as “NM23-B”, discovered based on 87.3% sequence similarity, was also found to interact with the telomeric DNA sequence (TTAGGG)6 [7]. Additionally, a close homologue of human NM23-H5 (NME5) recently found in the red alga Chondrus crispus—and therefore named NME5-likeCc—was also found to interact with telomeric DNA (TTAGGG)6 in vitro [8].

2.2. NM23-H2 Interaction with Telomere-Like G-Quadruplex Motif at the c-MYC Promoter

In 1993, Postel et al. identified the human c-MYC purine-binding factor (PuF)—named based on the characteristic G-rich DNA binding by the transcription factor—to be NM23-H2 [9]. Later work showed that NM23-H2 associated with the G-quadruplex DNA secondary structure formed by the G-rich DNA sequence present within the nuclease hypersensitive element (NHE) of the c-MYC promoter [10]. G-quadruplexes were initially noted to be formed by the interspersed GGG repeat-containing sequence found at the telomeres [11]. Similar interspersed GGG repeats identified at the c-MYC promoter NHE that formed telomere-like G-quadruplex, along with NM23-H2 association with telomeric DNA (discussed above), supported NM23-H2-G-quadruplex interactions. Disruption of the G-quadruplex by specific base substitutions, or in the presence of intracellular G-quadruplex binding molecules, resulted in altered binding of NM23-H2 to the c-MYC promoter. In addition, in vitro studies using recombinant NM23-H2 showed NM23-H2-G-quadruplex binding [10]. Recent work further shows NM23-H2 association with the G-quadruplexes at the hTERT promoter to be important for the epigenetic regulation of hTERT (vide infra) [12]. Interestingly, NM23-H2 was also shown to bind the i-motif formed from single-stranded C-rich DNA at the c-MYC promoter NHE [13].

2.3. NM23-H2 Interacts with Telomeres Inside Cells

While the findings discussed above demonstrated the interaction of NM23-H2 with telomeric DNA in vitro, evidence supporting NM23-H2 binding to telomeres in vivo was shown in 2012. In both A549 lung carcinoma and HT1080 fibrosarcoma cell lines, NM23-H2 chromatin immunoprecipitation followed by sequencing (ChIP-seq) was performed following expression MYC-tagged-NM23-H2. On analysis of the short sequence reads, for every million ChIP-seq about 6000–9000 reads were from the telomeric region comprising three or four telomeric repeats (TTAGGG/CCCTAA) (Figure 1). Here, it is important to note that because of ChIP with the anti-MYC antibody (against MYC-tagged NM23-H2), chances of cross-reactivity with NM23-H1 were unlikely. Further, ChIP experiments for both NM23-H1 and H2 showed that while NM23-H2 had occupancy on telomeric repeats, this was not so for NM23-H1 [5].

2.4. Interaction of the Telomere Binding Factor TRF1 and TRF2 with NM23-H2

The shelterin is an essential multi-protein complex that prevents the telomere ends from being detected as DNA double-stranded breaks, thereby preventing the activation of DNA damage signalling [14]. The shelterin also mediates telomere maintenance by assisting the recruitment of telomerase (the specialized reverse transcriptase holo-enzyme (TERT) that synthesizes telomeres) to the telomeres [15]. Telomere repeat binding factors 1 and 2 (TRF1 and TRF2) are DNA binding proteins essential for the assembly of the shelterin [16].
The direct association of NM23-H1 and H2 with TRF2 was tested. Here, the authors found co-immunoprecipitation (co-IP) of TRF2 with NM23-H2 from nuclear extracts of HT1080 fibrosarcoma and A549 lung carcinoma cell lines. This was further validated using reverse-IP using pull-down with anti-TRF2 antibody, where interaction with NM23-H2 was observed. Since both NM23-H2 and TRF2 were known to interact with DNA, it was further tested if NM23-H2-TRF2 interaction was dependent on their association with DNA. NM23-H2-TRF2 interaction was found to be independent of DNA or RNA association [5]. Consistent with previous reports, no interaction was noted between NM23-H1 and TRF2.
Earlier work using the yeast two-hybrid method showed the interaction of a truncated TRF1 protein (14-285aa) with NM23-H2; the interaction of TRF1 with NM23-H1, however, was not significant. Further, the authors used recombinant GST-tagged NM23-H1 and H2 and translated full-length TRF1 with S35 labelled methionine in vitro to confirm a strong and direct association of NM23-H2 with TRF1. The interaction of NM23-H1 with TRF1 was again found to be insignificant [6].

2.5. Human Telomerase Physically Associates with NM23-H2

The ribonucleoprotein reverse transcriptase telomerase binds to the 3’ overhangs of the telomeres and processes telomere elongation [17]. Telomerase hyper-activation is found in >90% of cancers and is known to support telomere maintenance in fast-dividing tumour cells [17,18]. Like NM23-H1 and H2, telomerase has also been associated with metastasis [19,20,21,22,23,24,25,26]. Based on findings supporting the presence of NM23-H2 at telomeres, the interaction of NM23-H2 with human telomerase (hTERT) was tested using co-IP experiments. Based on results from these experiments using nuclear extracts of HT1080 fibrosarcoma and A549 lung carcinoma cells, authors concluded that NM23-H2 associates with hTERT inside cells [5].
Further, it was observed that NM23-H2 over-expression suppressed hTERT enzymatic activity in HT1080 fibrosarcoma cells. This was independent of the nuclease activity of NM23-H2, suggesting that NM23-H2 did not suppress telomerase activity by cleaving the template DNA necessary for telomere elongation by hTERT [5]. As expected, the prolonged over-expression of NM23-H2 resulted in telomere shortening in MDA-MB-231 breast cancer cells, further supporting the role of NM23-H3 in the suppression of telomerase activity [27].
While these results supported an inverse relationship between NM23-H2 and telomerase, notably, NM23-H2 and telomerase activity when tested in hepatocellular carcinoma (HCC) patient samples showed that NM23-H2 levels positively correlated with telomerase activity [28]. Here, it is important to note that NM23-H2 is mainly localized in the cytoplasm, instead of the nuclei, in hepatocellular carcinoma cells [29].
Other than TRF2 and hTERT, the nuclear interactome of NM23-H2 (from mass spectrometry data) showed that telomere-associated proteins flap-endonuclease-1 (FEN1) and Lamin A/C/B1 interacted with NM23-H2 [12,30,31,32]. Additionally, NM23-H1 levels were reported earlier to directly co-relate with FEN1 mRNA in melanoma cell lines [33,34]. Further studies would be required to understand the functional implications of these newly detected interactions.

2.6. NM23-H2-Mediated Epigenetic Regulation of Human Telomerase Transcription

In addition to physical interaction with telomerase, direct transcriptional control of the hTERT by NM23-H2 was reported. From NM23-H2 ChIP in HT1080 fibrosarcoma and HCT116 colorectal cancer cell lines, NM23-H2 binding at the hTERT promoter was found within +40 to -250 bp upstream of the hTERT transcription start site [12]. NM23-H2 silencing induced hTERT gene expression in HT1080 and HCT116 cancer cells, and MRC5 normal primary lung fibroblast cells. NM23-H2 mediated transcriptional repression of hTERT was dependent on its DNA binding activity: the N69H and R34A DNA binding mutants of NM23-H2 could not repress hTERT expression. The authors also observed that NM23-H2 binding was dependent on the hTERT promoter G-quadruplex. In the case of base substitutions that disrupted the hTERT promoter G-quadruplex, NM23-H2 binding was lost from the hTERT core-promoter. This also resulted in the loss of the NM23-H2-mediated suppression of hTERT [12].
More detailed mechanistic experiments showed that NM23-H2 interacts with the REST/co-REST/LSD1/HDAC1/2 repressor complex, and this retained the non-permissive epigenetic state of the hTERT promoter. While lysine-specific demethylase 1 (LSD1) binding on the hTERT promoter was reported previously, this study demonstrated that LSD1 was recruited onto the hTERT core-promoter by NM23-H2. Based on the findings from the NM23-H2 nuclear interactome (mass-spectrometric analysis), and because LSD1 was known to be a part of the REST/co-REST/LSD1/HDAC1/2 repressor complex, the interaction of NM23-H2 with the remaining members of the multiprotein repressor complex was tested. Co-Immunoprecipitation experiments with anti NM23-H2 antibody showed enrichment for REST, LSD-1, HDAC1 and HDAC2. In the presence of NM23-H2, the repressor complex was shown to remain bound to the hTERT promoter. To further test the effect of NM23-H2 on the repressor complex, NM23-H2 was silenced. This resulted in a gain of H3K4me1, H3K4me2, and H3K9ac activation marks onto the hTERT promoter, as expected [12]. Taken together, these show that NM23-H2 suppresses telomerase transcriptionally as well as post-translationally (Figure 2).
Further, the authors treated cancer cells with G-quadruplex stabilizing ligands and demonstrated their repressive effect on hTERT expression. The effect was further confirmed using hTERT promoter activity. These data highlight the potential of G-quadruplex stabilizing ligands as anti-cancer therapeutic agents that could function by telomerase suppression. In this context, it would be interesting to test the effect of G-quadruplex stabilizing ligands on cancers with hTERT promoter mutations [35,36], more so since these mutations are single base transitions of G > A and are known to disrupt the hTERT promoter G-quadruplex [37,38,39].

3. Putative Telomere Dependent and Independent Role of the NM23NDPK Variants in Ageing and Cancer

3.1. Potential Role of NM23-H4 in Regulation of Ageing

NM23-H4 (also known as NDPK-D) has been reported for its dual functions as a mitochondrial nucleoside diphosphate kinase and a mediator of selective membrane phospholipid transfer [40]. As a mitochondrial nucleoside diphosphate kinase, it maintains the GTP pool for the dynamin-like mitochondrial GTPase Optic Atrophy 1 (OPA1) [40]. Further, NM23-H4 was shown to facilitate the externalization of the mitochondrial inner membrane phospholipid cardiolipin (CL) in response to stress, regulating mitophagy [41,42]. Lipid-mediated mitophagy has been observed to be important in regulating mitochondrial quality checks in neuroblastomas and neuronal cells, and its dysregulation is associated with age-related neurodegenerative disorders, such as Alzheimer’s disease [43,44]. It is of interest to note that while an enzymatically active NM23-H4 was required for interaction with OPA1, binding to and externalization of CL was through a kinase-inactive form of NM23-H4 [40,41]. A report also suggests the nuclear localization of NM23-H4 mediated by SIRT1, an NAD+ dependent deacetylase, by modulating the acetylation levels of the protein in N1E-115 mouse neuroblastoma cells [45]. However, these assays were performed by overexpressing Myc-tagged NM23-H4 and HA-tagged SIRT1, and hence require further confirmation with endogenous proteins. These indicate a possible differential temporal localization of the different NM23-H4 forms inside the cell, reflecting the status of cellular health and age. The mitochondrial NM23 protein also regulates mitochondrial DNA (mtDNA) stability by maintaining organellar deoxyribonucleotide-triphosphate (dNTP) metabolism, further regulating reactive oxygen species (ROS) generation, telomere, and chromosomal stability, which are important early events in ageing and cancer [46,47].

3.2. NM23-H1 Levels Alter during Ageing-Related Disorders

Reports of NDPK family proteins associated with age-related disorders suggest the significance of NDPK in the physiological process of ageing. Based on increased specific activity in brain tissue compared to others during embryonic development, NDPK proteins were deemed to be important for neuronal functions and developmental stages in the late 1990s [48]. More recent proteomic analyses (2D gel electrophoresis followed by Matrix assisted lazer desorption/ionization mass-spectrometery (MALDI-MS) of tissues from different brain regions of patients with Alzheimer’s disease (AD) and Down’s Syndrome (DS) with AD-like neural pathology presented an important observation: NM23-H1 (also known as NDPK A) expression is substantially reduced in the frontal, parietal and occipital cortices. In addition, the enzymatic activity of NM23-H1 was also found to be reduced compared to the control. However, though no correlation could be established between reduced protein levels and activity, the study reasoned that the possibility of oxidative modification of NM23-H1 gave reduced enzymatic activity. This is concordant with the increased oxidative stress symptoms of AD [49]. Together, the maintenance of NDPK levels in specific tissues might be important in ageing and ageing-related diseases. Higher nuclear levels of NM23-H1 were also found to serve as a better prognostic marker for laryngeal squamous cell carcinoma (LSCC) in elderly patients [50]. The clinical study found around 60% (31 out of 54) of surgical specimens of LSCC patients to have nuclear NM23-H1 localization and a significantly longer disease-free survival (DFS) in patients with nuclear expression above a Receiver Operating Curve (ROC) determined cut-off level of 2%. Although a mechanistic explanation for better LSCC prognosis via age-dependent nuclear NM23-H1 expression was not explored, the possibility of its role in DNA binding and ageing-associated DNA damage-repair/response was highlighted [34,50].

3.3. Cytoskeleton Modulation by NM23/NDPK Proteins in Cancer and Ageing

Cytoskeletal modulations play a critical role in cellular and organismal ageing, neural degeneration, and cancer [51,52]. Various NDPK family proteins have been extensively reported to be associated with all the three major cytoskeleton components—actin, microtubules, and intermediate filaments, and their interacting proteins [53]. These interactions were also noted to be significant in regulating cell division and migratory movements in cancer. The interaction of gelsolin (actin-depolymerizing protein) with NM23-H1 was reported to inhibit actin filament generation, and this was associated with the metastasis inhibitory function of NM23-H1 [54]. NM23-H1 also binds to dynamin (a GTPase) involved mainly in E-cadherin endocytosis that regulates migratory/invasive properties in tumours [55]. During telophase-cytokinesis, NM23-H1 localizes in the cellular cortex, specifically at the equatorial region, wherein by binding to dynamin-1 it facilitates the formation of the cleavage furrow via actin organization [56]. Failure to do so leads to the generation of aneuploid cells, chromosomal instability, and tumourigenesis, and induces senescence in p53 expressing primary cells [56]. It would be important to note here that damage to the telomeres, which tether chromosomes to the nuclear envelope in a laminA/C dependent fashion through the linker-of-nucleoskeleton-and-cytoskeleton (LINC) complex SUN1 and SUN2 during telophase, inhibits cytokinesis [57,58]. As discussed earlier, NM23-H2 associates with lamin-A, suggesting that connections among telomeres, NM23H1/H2, and the cytoskeleton might be of significance in ageing [12,59,60]. Stathmin (Op 18), a microtubule destabilizing protein important for neuronal differentiation, was reported to be regulated by NDPK [61]. Interestingly, in addition to the drop in NM23-H1 expression in AD and DS disorders, Op18 expression also decreases. Together, these make a case for the involvement of NDPK family proteins in ageing [62].

4. Role of NM23/NDPKs in T-Cell Activation—Potential Telomerase Connection

4.1. NM23-H2/NDPK-B Mediated T Cell Activation

T cell activation is an indispensable arm of the adaptive immune response against foreign antigens. Factors and mechanisms governing the activation and amplification of T cells have been studied extensively. T cells derive the name from “Thymus”, where they are generated and programmed specifically for a particular antigen. T cells exit from the Thymus and enter into circulation, where they recognize their specific antigen presented on the surface of antigen-presenting cells (APCs) held by the Major histo-compatibility (MHC) complex. Antigen and T cell receptor (TCR) binding both in CD4+ helper and CD8+ cytotoxic T cells triggers T cell activation [63,64,65]. Antigen interaction is known to be accompanied by calcium (Ca2+) influx as an essential signal for the reactivation of naïve (in-activated/resting) T cells [66].
Ca2+ influx into T cells occurs via Ca2+ release-activated channels (CARC) present in the plasma membrane. CARC channels function by activating K+ channels (calcium-activated K+ channels, also known as IK Ca2+, small conductance calcium-activated potassium channel KCa3.1 ((SK)4, or KCNN4)). Therefore, CARC channels mediate Ca2+ influx via K+ efflux. Increased cytosolic Ca2+ activates phosphatase calcineurin, which mediates the assembly of Nuclear factor of activated T cell (NFAT) transcriptional complexes [66]. This initiates the transcription of genes essential for T cell activation and proliferation.
NDPK-B/NM23-H2 was shown to activate KCa3.1 by directly binding and phosphorylating histidine (358) at its carboxyl terminus. H358 phosphorylation by NDPK-B was found to be essential for KCa3.1 channel activation, Ca2+ influx, and the proliferation of human CD4 T cells [67]. This study provided one of the first functions of histidine phosphorylation in mammals, governing an essential biological pathway. Later, the same group developed NDPK-B/NM23-H2 null (−/−) mice. These mice were phenotypically normal at birth and had a normal life span, with normal T and B cell development. However, cytokine production and T cell activation were markedly defective in NDPK-B (−/−) mice. The authors identified that KCa3.1 channel activity was significantly compromised in both T helper 1 (Th1) and Th2 cells. Additionally, they isolated T cells from NDPK-B (−/−) mice and tested them in-vitro. T cell activation was found to be impeded due to Kca3.1 channel dysfunction [68]. Further NDPK-B silencing was shown to abrogate T cell activation [67,69]. Together, these highlight the importance of NDPK-B in KCa3.1 function, and thereby T cell activation.

4.2. Potential Role of NM23-H2 in Telomerase Re-Activation during T Cell Activation

The molecular mechanisms underlying calcium signalling in T cell activation have been known for a long time [66]. Telomerase regulation and changes in telomere length during T cell activation have been studied [70,71,72,73]. Like other somatic cellular lineages, immune cells also undergo telomere shortening with cell divisions and ageing. T cell activation induces cells for further proliferation. Consistent with this, telomerase was found to be re-activated with T cell activation [74,75,76]. In a study conducted with six T cell subsets from 111 human adults, both hTERT mRNA and telomerase activity were found to sequentially decrease from naïve (TN) to central memory (TCM) to effector memory (TEM) cells. CD4+ cells had higher telomerase in comparison to the corresponding CD8+ subsets [76]. The robustness of T cell response was also found to be directly related to the telomere length of patient-derived activated T cells. This suggests that the gain of telomerase expression could be used to therapeutically improve the T cell function in the elderly [76,77,78]. These studies underscore the importance of telomerase and telomere length regulation in T cell response. T cell activation by phorbol myristate acetate (PMA)/ionomycin was shown to activate telomerase activity as well as calcium influx [66,70,71,72,73]. In addition to the above, while not directly in T cells, the effect of cytoplasmic calcium levels on telomere length has been demonstrated [79].
More than one mechanism of telomerase re-activation has been implicated to be involved during T cell activation. These include cytokine-mediated (IL-7 and IL-15) upregulation and NFAT-sp1 mediated transcriptional re-activation, and while not tested in T cells, the role of c-myc in telomerase re-activation has also been discussed, along with the post-transcriptional stabilization of telomerase transcripts (reviewed in [80,81,82]. While multiple mechanisms have been implicated, none of them have been directly elucidated to control telomerase re-activation during T cell activation. Although not in T cells, NM23-H2/NDPK-B was also reported to transcriptionally as well as post-transcriptionally suppress telomerase [5,12].
It is possible, therefore, that the NM23-H2 mediated transcriptional regulation of hTERT might be of significance in the regulation of telomerase in T cells. Further, as described above, the possibility of T cell activation being dependent on Ca2+ influx mediated by NDPK-B/NM23-H2 kinase activity is interesting (Figure 3). Together, these implicate a dual role of NM23/NDPK proteins in T-cell activation.

5. Emerging Aspects and Future Questions

The binding of NM23 proteins to telomeres presents an interesting aspect; however, it has not been directly associated with any function. It remains unknown if NM23 proteins are involved in telomere protection and therefore affect genome stability. Since telomeric damage is long known to be associated with ageing, it could be explored if NM23 proteins have a role in regulating genome stability along with the secondary conformation of telomeres, in association with TRF1/2 [83]. Moreover, do NM23 proteins also interact with other proteins of the shelterin complex? The shelterin is also known to change composition based on physiological conditions [84]. Do NM23 proteins have any role to play in this aspect? Further, it would be interesting to study if NM23-H2, in association with TRF2 or independently, binds throughout telomeres, or not.
The interaction of NM23 proteins with telomere binding proteins such as those involved in telomere stability (TRF2) [85] and maintenance (telomerase) [86] has not been associated with the enzymatic activity of NM23 proteins. It might be possible that the kinase activity of NM23 proteins impacts TRF2/telomerase function, as both TRF2 and telomerase are known to be phosphorylated, and have phosphorylation-dependent functions [87].
Kar et al. demonstrated the nuclear interaction of NM23-H2 with hTERT that was found to be independent of DNA binding [5]. However, hTERT is also known to localize in mitochondria and activate mitophagy [88]. While the mitochondrial localization of NM23-H2 is not known, NM23-H4 is a mitochondrial NDPK [89]. It might be interesting to study whether NM23-H4 associates with hTERT in mitochondria, and if this association has any role in mitochondrial functions.
hTERT is also known to activate the transcription of several gene targets [90,91]. The interaction of NM23 with hTERT, therefore, may influence transcriptomic alterations. Together, this raises the question about whether, and if so, how, the nucleic acid-independent interactions of NM23-H2 influence gene expression across the genome.
Another important aspect of NM23-H2 is its association with TRF1/TRF2. These interactions might be crucial in genome-wide telomere length-dependent transcriptome changes. This is because, recently, the extra-telomeric association of TRF2 was shown to extensively impact genome-wide gene expression changes that were dependent on telomere length [92].
Additionally, similar to NM23-H2, TRF2 is also shown to bind to G-quadruplexes and gene promoters carrying potential G-quadruplex forming sequences [93,94,95]. Therefore, NM23-H2-TRF2 interaction suggests potential co-regulation through association with G-quadruplexes. An example of this is the regulation of hTERT, where independently both NM23-H2 [12] and TRF2 [96] have been observed to control hTERT by binding to promoter G-quadruplexes.
We further highlight the indications from the association of NM23-H2 with lamins and FEN1 [12]. TRF2 is also known to interact with A-lamins, thereby mediating the chromosome looping of telomeres [97,98]. In this light, further understanding of Lamins/TRF1/2/NM23-H2 or FEN1/NM23-H2 associations might provide meaningful insights into the role of NM23 proteins in telomere biology.
Finally, multiple pieces of evidence of the mitochondrial NM23 protein suggests an association with ageing. Simultaneously, observations on the cytoskeleton, NM23 family proteins, telomeres, and ageing are connected. These suggest potential roles of NM23 proteins that remain to be addressed. Further work will be required to illuminate these molecular interactions and the implications of such cross-talk, if any.

6. Conclusions

NM23 proteins have multiple activities and functions that assist their metastasis suppressor role. While some of these are well understood, others continue to be explored. Here, we discussed the interactions and regulatory effects of NM23 proteins related to telomeres and telomere-binding proteins (Table 1). The emerging literature on NM23-H2 and NM23-H5-like proteins with telomeres suggests the possibility of telomere binding by other NM23 proteins.
The dual regulation of telomerase, both at the transcriptional and post-translational levels, by NM23-H2 emphasizes its regulatory effect on telomeres and telomere-associated functions, including metastasis and ageing. While based on current findings it is difficult to say whether NM23 proteins have any role in these aspects, it would be interesting to investigate the reasons and implications of NM23 association with telomeres and telomere binding proteins.
Additionally, the role of NM23 proteins needs to be further explored with reference to ageing-associated pathologies. From the association of NM23 proteins with the initiation/progression of diseases such as Alzheimer’s, progeria and cancer, it is possible that NM23 family members might influence pathological contexts. Direct exploration of these questions would be important.

Author Contributions

S.S. and S.C.: Conceptualization and planning; S.S.: NM23 proteins associating with telomeres and their potential role in T cell activation; A.S.: putative role of NM23-H4 in ageing and NM23 proteins emerging telomeric roles; S.C.: review writing and compilation. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.APC was funded by DBT/Wellcome Trust India Alliance Fellowship [grant number IA/S/18/2/504021].

Acknowledgments

For research fellowships, S.S. and A.S. acknowledge CSIR.

Conflicts of Interest

The authors report no conflict of interest.

References

  1. Boissan, M.; Dabernat, S.; Peuchant, E.; Schlattner, U.; Lascu, I.; Lacombe, M.-L. The Mammalian Nm23/NDPK Family: From Metastasis Control to Cilia Movement. Mol. Cell. Biochem. 2009, 329, 51–62. [Google Scholar] [CrossRef]
  2. Sharma, S.; Sengupta, A.; Chowdhury, S. NM23/NDPK Proteins in Transcription Regulatory Functions and Chromatin Modulation: Emerging Trends. Lab. Investig. 2018, 98, 175–181. [Google Scholar] [CrossRef] [Green Version]
  3. Boissan, M.; Schlattner, U.; Lacombe, M.-L. The NDPK/NME Superfamily: State of the Art. Lab. Investig. 2018, 98, 164–174. [Google Scholar] [CrossRef] [PubMed]
  4. Hartsough, M.T.; Steeg, P.S. Nm23/Nucleoside Diphosphate Kinase in Human Cancers. J. Bioenerg. Biomembr. 2000, 32, 301–308. [Google Scholar] [CrossRef]
  5. Kar, A.; Saha, D.; Purohit, G.; Singh, A.; Kumar, P.; Yadav, V.K.; Kumar, P.; Thakur, R.K.; Chowdhury, S. Metastases Suppressor NME2 Associates with Telomere Ends and Telomerase and Reduces Telomerase Activity within Cells. Nucleic Acids Res. 2012, 40, 2554–2565. [Google Scholar] [CrossRef] [Green Version]
  6. Nosaka, K.; Kawahara, M.; Masuda, M.; Satomi, Y.; Nishino, H. Association of Nucleoside Diphosphate Kinase Nm23-H2 with Human Telomeres. Biochem. Biophys. Res. Commun. 1998, 243, 342–348. [Google Scholar] [CrossRef]
  7. Lee, J.-S.; Lee, S.-H. Cloning and Characterization of CDNA Encoding Zebrafish Danio Rerio NM23-B Gene. Gene 2000, 245, 75–79. [Google Scholar] [CrossRef]
  8. Perina, D.; Korolija, M.; Mikoč, A.; Halasz, M.; Herak Bosnar, M.; Ćetković, H. Characterization of Nme5-Like Gene/Protein from the Red Alga Chondrus Crispus. Mar. Drugs 2019, 18, 13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Postel, E.H.; Berberich, S.J.; Flint, S.J.; Ferrone, C.A. Human C-Myc Transcription Factor PuF Identified as Nm23-H2 Nucleoside Diphosphate Kinase, a Candidate Suppressor of Tumor Metastasis. Science 1993, 261, 478–480. [Google Scholar] [CrossRef]
  10. Thakur, R.K.; Kumar, P.; Halder, K.; Verma, A.; Kar, A.; Parent, J.-L.; Basundra, R.; Kumar, A.; Chowdhury, S. Metastases Suppressor NM23-H2 Interaction with G-Quadruplex DNA within c-MYC Promoter Nuclease Hypersensitive Element Induces c-MYC Expression. Nucleic Acids Res. 2009, 37, 172–183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Sen, D.; Gilbert, W. Formation of Parallel Four-Stranded Complexes by Guanine-Rich Motifs in DNA and Its Implications for Meiosis. Nature 1988, 334, 364–366. [Google Scholar] [CrossRef] [PubMed]
  12. Saha, D.; Singh, A.; Hussain, T.; Srivastava, V.; Sengupta, S.; Kar, A.; Dhapola, P.; Dhople, V.; Ummanni, R.; Chowdhury, S. Epigenetic Suppression of Human Telomerase (HTERT) Is Mediated by the Metastasis Suppressor NME2 in a G-Quadruplex-Dependent Fashion. J. Biol. Chem. 2017, 292, 15205–15215. [Google Scholar] [CrossRef] [Green Version]
  13. Hildebrandt, M.; Lacombe, M.L.; Mesnildrey, S.; Véron, M. A Human NDP-Kinase B Specifically Binds Single-Stranded Poly-Pyrimidine Sequences. Nucleic Acids Res. 1995, 23, 3858–3864. [Google Scholar] [CrossRef] [Green Version]
  14. Sfeir, A.; de Lange, T. Removal of Shelterin Reveals the Telomere End-Protection Problem. Science 2012, 336, 593–597. [Google Scholar] [CrossRef] [Green Version]
  15. Roake, C.M.; Artandi, S.E. Regulation of Human Telomerase in Homeostasis and Disease. Nat. Rev. Mol. Cell Biol. 2020, 21, 384–397. [Google Scholar] [CrossRef]
  16. De Lange, T. Shelterin: The Protein Complex That Shapes and Safeguards Human Telomeres. Genes Dev. 2005, 19, 2100–2110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Jafri, M.A.; Ansari, S.A.; Alqahtani, M.H.; Shay, J.W. Roles of Telomeres and Telomerase in Cancer, and Advances in Telomerase-Targeted Therapies. Genome Med. 2016, 8, 69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Shay, J.W.; Wright, W.E. Role of Telomeres and Telomerase in Cancer. Semin. Cancer Biol. 2011, 21, 349–353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Bagheri, S.; Nosrati, M.; Li, S.; Fong, S.; Torabian, S.; Rangel, J.; Moore, D.H.; Federman, S.; Laposa, R.R.; Baehner, F.L.; et al. Genes and Pathways Downstream of Telomerase in Melanoma Metastasis. Proc. Natl. Acad. Sci. USA 2006, 103, 11306–11311. [Google Scholar] [CrossRef] [Green Version]
  20. Saito, Y.; Kosugi, S.; Suda, T.; Wakabayashi, Y.; Mishima, Y.; Hatakeyama, K.; Kominami, R. Telomerase Activity and Metastasis: Expansion of Cells Having Higher Telomerase Activity within Culture Lines and Tumor Tissues. Jpn. J. Cancer Res. 1997, 88, 732–737. [Google Scholar] [CrossRef] [PubMed]
  21. Chang, S.; Khoo, C.M.; Naylor, M.L.; Maser, R.S.; DePinho, R.A. Telomere-Based Crisis: Functional Differences between Telomerase Activation and ALT in Tumor Progression. Genes Dev. 2003, 17, 88–100. [Google Scholar] [CrossRef] [Green Version]
  22. Robinson, N.J.; Schiemann, W.P. Means to the Ends: The Role of Telomeres and Telomere Processing Machinery in Metastasis. Biochim. Biophys. Acta 2016, 1866, 320–329. [Google Scholar] [CrossRef] [Green Version]
  23. Fernández-Marcelo, T.; Gómez, A.; Pascua, I.; de Juan, C.; Head, J.; Hernando, F.; Jarabo, J.-R.; Calatayud, J.; Torres-García, A.-J.; Iniesta, P. Telomere Length and Telomerase Activity in Non-Small Cell Lung Cancer Prognosis: Clinical Usefulness of a Specific Telomere Status. J. Exp. Clin. Cancer Res. 2015, 34, 78. [Google Scholar] [CrossRef] [Green Version]
  24. Viceconte, N.; Dheur, M.-S.; Majerova, E.; Pierreux, C.E.; Baurain, J.-F.; van Baren, N.; Decottignies, A. Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length. Cell Rep. 2017, 19, 2529–2543. [Google Scholar] [CrossRef] [Green Version]
  25. Bojovic, B.; Crowe, D.L. Dysfunctional Telomeres Promote Genomic Instability and Metastasis in the Absence of Telomerase Activity in Oncogene Induced Mammary Cancer. Mol. Carcinog. 2013, 52, 103–117. [Google Scholar] [CrossRef]
  26. Griffith, J.K.; Bryant, J.E.; Fordyce, C.A.; Gilliland, F.D.; Joste, N.E.; Moyzis, R.K. Reduced Telomere DNA Content Is Correlated with Genomic Instability and Metastasis in Invasive Human Breast Carcinoma. Breast Cancer Res. Treat. 1999, 54, 59–64. [Google Scholar] [CrossRef]
  27. Kar, A.; Chowdhury, S. Inhibition of Telomerase Activity by NME2: Impact on Metastasis Suppression? Naunyn Schmiedebergs Arch. Pharm. 2015, 388, 235–241. [Google Scholar] [CrossRef] [Green Version]
  28. Iizuka, N.; Mori, N.; Tamesa, T.; Tangoku, A.; Oka, M. Telomerase Activity and Nm23-H2 Protein Expression in Hepatocellular Carcinoma. Anticancer Res. 2003, 23, 43–47. [Google Scholar]
  29. Lee, M.-J.; Xu, D.-Y.; Li, H.; Yu, G.-R.; Leem, S.-H.; Chu, I.-S.; Kim, I.-H.; Kim, D.-G. Pro-Oncogenic Potential of NM23-H2 in Hepatocellular Carcinoma. Exp. Mol. Med. 2012, 44, 214–224. [Google Scholar] [CrossRef]
  30. Saharia, A.; Guittat, L.; Crocker, S.; Lim, A.; Steffen, M.; Kulkarni, S.; Stewart, S.A. Flap Endonuclease 1 Contributes to Telomere Stability. Curr. Biol. 2008, 18, 496–500. [Google Scholar] [CrossRef] [Green Version]
  31. Dechat, T.; Gajewski, A.; Korbei, B.; Gerlich, D.; Daigle, N.; Haraguchi, T.; Furukawa, K.; Ellenberg, J.; Foisner, R. LAP2alpha and BAF Transiently Localize to Telomeres and Specific Regions on Chromatin during Nuclear Assembly. J. Cell. Sci. 2004, 117, 6117–6128. [Google Scholar] [CrossRef] [Green Version]
  32. Gonzalo, S.; Eissenberg, J.C. Tying up Loose Ends: Telomeres, Genomic Instability and Lamins. Curr. Opin. Genet. Dev. 2016, 37, 109–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Puts, G.S.; Leonard, M.K.; Pamidimukkala, N.V.; Snyder, D.E.; Kaetzel, D.M. Nuclear Functions of NME Proteins. Lab. Investig. 2018, 98, 211–218. [Google Scholar] [CrossRef]
  34. Kaetzel, D.M.; Zhang, Q.; Yang, M.; McCorkle, J.R.; Ma, D.; Craven, R.J. Potential Roles of 3’-5’ Exonuclease Activity of NM23-H1 in DNA Repair and Malignant Progression. J. Bioenerg. Biomembr. 2006, 38, 163–167. [Google Scholar] [CrossRef] [PubMed]
  35. Mukherjee, A.K.; Sharma, S.; Chowdhury, S. Non-Duplex G-Quadruplex Structures Emerge as Mediators of Epigenetic Modifications. Trends Genet. 2019, 35, 129–144. [Google Scholar] [CrossRef] [Green Version]
  36. Sengupta, A.; Ganguly, A.; Chowdhury, S. Promise of G-Quadruplex Structure Binding Ligands as Epigenetic Modifiers with Anti-Cancer Effects. Molecules 2019, 24, 582. [Google Scholar] [CrossRef] [Green Version]
  37. Horn, S.; Figl, A.; Rachakonda, P.S.; Fischer, C.; Sucker, A.; Gast, A.; Kadel, S.; Moll, I.; Nagore, E.; Hemminki, K.; et al. TERT Promoter Mutations in Familial and Sporadic Melanoma. Science 2013, 339, 959–961. [Google Scholar] [CrossRef] [Green Version]
  38. Huang, F.W.; Hodis, E.; Xu, M.J.; Kryukov, G.V.; Chin, L.; Garraway, L.A. Highly Recurrent TERT Promoter Mutations in Human Melanoma. Science 2013, 339, 957–959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Kang, H.-J.; Cui, Y.; Yin, H.; Scheid, A.; Hendricks, W.P.D.; Schmidt, J.; Sekulic, A.; Kong, D.; Trent, J.M.; Gokhale, V.; et al. A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant HTERT Promoters. J. Am. Chem. Soc. 2016. [Google Scholar] [CrossRef] [Green Version]
  40. Schlattner, U.; Tokarska-Schlattner, M.; Ramirez, S.; Tyurina, Y.Y.; Amoscato, A.A.; Mohammadyani, D.; Huang, Z.; Jiang, J.; Yanamala, N.; Seffouh, A.; et al. Dual Function of Mitochondrial Nm23-H4 Protein in Phosphotransfer and Intermembrane Lipid Transfer: A Cardiolipin-Dependent Switch. J. Biol. Chem. 2013. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Kagan, V.E.; Jiang, J.; Huang, Z.; Tyurina, Y.Y.; Desbourdes, C.; Cottet-Rousselle, C.; Dar, H.H.; Verma, M.; Tyurin, V.A.; Kapralov, A.A.; et al. NDPK-D (NM23-H4)-Mediated Externalization of Cardiolipin Enables Elimination of Depolarized Mitochondria by Mitophagy. Cell Death Differ. 2016, 23, 1140–1151. [Google Scholar] [CrossRef] [Green Version]
  42. Schlattner, U.; Tokarska-Schlattner, M.; Epand, R.M.; Boissan, M.; Lacombe, M.L.; Kagan, V.E. NME4/Nucleoside Diphosphate Kinase D in Cardiolipin Signaling and Mitophagy. Lab. Investig. 2018, 98, 228–232. [Google Scholar] [CrossRef] [PubMed]
  43. Chu, C.T.; Ji, J.; Dagda, R.K.; Jiang, J.F.; Tyurina, Y.Y.; Kapralov, A.A.; Tyurin, V.A.; Yanamala, N.; Shrivastava, I.H.; Mohammadyani, D.; et al. Cardiolipin Externalization to the Outer Mitochondrial Membrane Acts as an Elimination Signal for Mitophagy in Neuronal Cells. Nat. Cell Biol. 2013, 15, 1197–1205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Cai, Q.; Jeong, Y.Y. Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases. Cells 2020, 9, 150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Fujita, Y.; Fujiwara, K.; Zenitani, S.; Yamashita, T. Acetylation of NDPK-D Regulates Its Subcellular Localization and Cell Survival. PLoS ONE 2015, 10, e0139616. [Google Scholar] [CrossRef] [Green Version]
  46. Miller, C.; Wang, L.; Ostergaard, E.; Dan, P.; Saada, A. The Interplay between SUCLA2, SUCLG2, and Mitochondrial DNA Depletion. Biochim. Biophys. Acta Mol. Basis Dis. 2011. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Zhao, Y.; Tian, J.; Sui, S.; Yuan, X.; Chen, H.; Qu, C.; Du, Y.; Guo, L.; Du, H. Loss of Succinyl-CoA Synthase ADP-Forming β Subunit Disrupts MtDNA Stability and Mitochondrial Dynamics in Neurons. Sci. Rep. 2017. [Google Scholar] [CrossRef] [Green Version]
  48. Ishijima, Y.; Shimada, N.; Fukuda, M.; Miyazaki, H.; Orlov, N.Y.; Orlova, T.G.; Yamada, T.; Kimura, N. Overexpression of Nucleoside Diphosphate Kinases Induces Neurite Outgrowth and Their Substitution to Inactive Forms Leads to Suppression of Nerve Growth Factor- and Dibutyryl Cyclic AMP-Induced Effects in PC12D Cells. FEBS Lett. 1999, 445, 155–159. [Google Scholar] [CrossRef] [Green Version]
  49. Kim, S.H.; Fountoulakis, M.; Cairns, N.J.; Lubec, G. Human Brain Nucleoside Diphosphate Kinase Activity Is Decreased in Alzheimer’s Disease and Down Syndrome. Biochem. Biophys. Res. Commun. 2002, 296, 970–975. [Google Scholar] [CrossRef]
  50. Lionello, M.; Blandamura, S.; Lovato, A.; Franchella, S.; Giacomelli, L.; Ottaviano, G.; Stellini, E.; Staffieri, A.; Marioni, G. A High Nuclear Nm23-H1 Expression Is Associated with a Better Prognosis in Elderly Patients with Laryngeal Carcinoma. Acta Otolaryngol. 2013, 133, 874–880. [Google Scholar] [CrossRef] [PubMed]
  51. Kounakis, K.; Tavernarakis, N. The Cytoskeleton as a Modulator of Aging and Neurodegeneration. Adv. Exp. Med. Biol. 2019, 1178, 227–245. [Google Scholar] [PubMed]
  52. Fife, C.M.; McCarroll, J.A.; Kavallaris, M. Movers and Shakers: Cell Cytoskeleton in Cancer Metastasis: Cytoskeleton and Cancer Metastasis. Br. J. Pharm. 2014, 171, 5507–5523. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Snider, N.T.; Altshuler, P.J.; Omary, M.B. Modulation of Cytoskeletal Dynamics by Mammalian Nucleoside Diphosphate Kinase (NDPK) Proteins. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2015. [Google Scholar] [CrossRef] [Green Version]
  54. Marino, N.; Marshall, J.-C.; Collins, J.W.; Zhou, M.; Qian, Y.; Veenstra, T.; Steeg, P.S. Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis. Cancer Res. 2013, 73, 5949–5962. [Google Scholar] [CrossRef] [Green Version]
  55. Boissan, M.; Montagnac, G.; Shen, Q.; Griparic, L.; Guitton, J.; Romao, M.; Sauvonnet, N.; Lagache, T.; Lascu, I.; Raposo, G.; et al. Membrane Trafficking. Nucleoside Diphosphate Kinases Fuel Dynamin Superfamily Proteins with GTP for Membrane Remodeling. Science 2014, 344, 1510–1515. [Google Scholar] [CrossRef] [Green Version]
  56. Conery, A.R.; Sever, S.; Harlow, E. Nucleoside Diphosphate Kinase Nm23-H1 Regulates Chromosomal Stability by Activating the GTPase Dynamin during Cytokinesis. Proc. Natl. Acad. Sci. USA 2010, 107, 15461–15466. [Google Scholar] [CrossRef] [Green Version]
  57. Baker, N.M.; Zeitlin, S.G.; Shi, L.Z.; Shah, J.; Berns, M.W. Chromosome Tips Damaged in Anaphase Inhibit Cytokinesis. PLoS ONE 2010, 5, e12398. [Google Scholar] [CrossRef] [Green Version]
  58. Schmitt, J.; Benavente, R.; Hodzic, D.; Höög, C.; Stewart, C.L.; Alsheimer, M. Transmembrane Protein Sun2 Is Involved in Tethering Mammalian Meiotic Telomeres to the Nuclear Envelope. Proc. Natl. Acad. Sci. USA 2007, 104, 7426–7431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Burla, R.; La Torre, M.; Saggio, I. Mammalian Telomeres and Their Partnership with Lamins. Nucleus 2016, 7, 187–202. [Google Scholar] [CrossRef] [Green Version]
  60. Liu, B.; Wang, J.; Chan, K.M.; Tjia, W.M.; Deng, W.; Guan, X.; Huang, J.; Li, K.M.; Chau, P.Y.; Chen, D.J.; et al. Genomic Instability in Laminopathy-Based Premature Aging. Nat. Med. 2005, 11, 780–785. [Google Scholar] [CrossRef]
  61. Andersen, S.S. Spindle Assembly and the Art of Regulating Microtubule Dynamics by MAPs and Stathmin/Op18. Trends Cell Biol. 2000, 10, 261–267. [Google Scholar] [CrossRef]
  62. Cheon, M.S.; Fountoulakis, M.; Cairns, N.J.; Dierssen, M.; Herkner, K.; Lubec, G. Decreased Protein Levels of Stathmin in Adult Brains with Down Syndrome and Alzheimer’s Disease. J. Neural Transm. Suppl. 2001, 281–288. [Google Scholar] [CrossRef]
  63. Dumont, F.J.; Staruch, M.J.; Koprak, S.L.; Melino, M.R.; Sigal, N.H. Distinct Mechanisms of Suppression of Murine T Cell Activation by the Related Macrolides FK-506 and Rapamycin. J. Immunol. 1990, 144, 251–258. [Google Scholar]
  64. Chen, L.; Flies, D.B. Molecular Mechanisms of T Cell Co-Stimulation and Co-Inhibition. Nat. Rev. Immunol. 2013, 13, 227–242. [Google Scholar] [CrossRef] [PubMed]
  65. Siller-Farfán, J.A.; Dushek, O. Molecular Mechanisms of T Cell Sensitivity to Antigen. Immunol. Rev. 2018, 285, 194–205. [Google Scholar] [CrossRef] [PubMed]
  66. Chatila, T.; Silverman, L.; Miller, R.; Geha, R. Mechanisms of T Cell Activation by the Calcium Ionophore Ionomycin. J. Immunol. 1989, 143, 1283–1289. [Google Scholar]
  67. Srivastava, S.; Li, Z.; Ko, K.; Choudhury, P.; Albaqumi, M.; Johnson, A.K.; Yan, Y.; Backer, J.M.; Unutmaz, D.; Coetzee, W.A.; et al. Histidine Phosphorylation of the Potassium Channel KCa3.1 by Nucleoside Diphosphate Kinase B Is Required for Activation of KCa3.1 and CD4 T Cells. Mol. Cell 2006, 24, 665–675. [Google Scholar] [CrossRef]
  68. Di, L.; Srivastava, S.; Zhdanova, O.; Sun, Y.; Li, Z.; Skolnik, E.Y. Nucleoside Diphosphate Kinase B Knock-out Mice Have Impaired Activation of the K+ Channel KCa3.1, Resulting in Defective T Cell Activation. J. Biol. Chem. 2010, 285, 38765–38771. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Srivastava, S.; Zhdanova, O.; Di, L.; Li, Z.; Albaqumi, M.; Wulff, H.; Skolnik, E.Y. Protein Histidine Phosphatase 1 Negatively Regulates CD4 T Cells by Inhibiting the K+ Channel KCa3.1. Proc. Natl. Acad. Sci. USA 2008, 105, 14442–14446. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Son, N.H.; Murray, S.; Yanovski, J.; Hodes, R.J.; Weng, N. Lineage-Specific Telomere Shortening and Unaltered Capacity for Telomerase Expression in Human T and B Lymphocytes with Age. J. Immunol. 2000, 165, 1191–1196. [Google Scholar] [CrossRef] [Green Version]
  71. Weng, N.P.; Levine, B.L.; June, C.H.; Hodes, R.J. Regulated Expression of Telomerase Activity in Human T Lymphocyte Development and Activation. J. Exp. Med. 1996, 183, 2471–2479. [Google Scholar] [CrossRef]
  72. Huang, E.E.; Tedone, E.; O’Hara, R.; Cornelius, C.; Lai, T.-P.; Ludlow, A.; Wright, W.E.; Shay, J.W. The Maintenance of Telomere Length in CD28+ T Cells During T Lymphocyte Stimulation. Sci. Rep. 2017, 7, 6785. [Google Scholar] [CrossRef] [Green Version]
  73. Bodnar, A.G.; Kim, N.W.; Effros, R.B.; Chiu, C.P. Mechanism of Telomerase Induction during T Cell Activation. Exp. Cell Res. 1996, 228, 58–64. [Google Scholar] [CrossRef] [PubMed]
  74. Kaban, A.P.; Gunina, L.M. Use of the indices of the kallikrein-kinin system of the blood in evaluating the efficacy of the prevention and treatment of postoperative purulent complications in oncologic patients. Klin. Khir. 1989, 10–12. [Google Scholar]
  75. Sawai, Y.; Sawasaki, Y.; Tsukada, K. Ribonuclease H Activity in Developing Rat Brain. Life Sci. 1977, 21, 1351–1356. [Google Scholar] [CrossRef]
  76. Patrick, M.S.; Cheng, N.-L.; Kim, J.; An, J.; Dong, F.; Yang, Q.; Zou, I.; Weng, N.-P. Human T Cell Differentiation Negatively Regulates Telomerase Expression Resulting in Reduced Activation-Induced Proliferation and Survival. Front. Immunol. 2019, 10, 1993. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Tedone, E.; Huang, E.; O’Hara, R.; Batten, K.; Ludlow, A.T.; Lai, T.-P.; Arosio, B.; Mari, D.; Wright, W.E.; Shay, J.W. Telomere Length and Telomerase Activity in T Cells Are Biomarkers of High-Performing Centenarians. Aging Cell 2019, 18, e12859. [Google Scholar] [CrossRef]
  78. Najarro, K.; Nguyen, H.; Chen, G.; Xu, M.; Alcorta, S.; Yao, X.; Zukley, L.; Metter, E.J.; Truong, T.; Lin, Y.; et al. Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older Adults. J. Infect. Dis. 2015, 212, 1261–1269. [Google Scholar] [CrossRef]
  79. O’Callaghan, N.J.; Bull, C.; Fenech, M. Elevated Plasma Magnesium and Calcium May Be Associated with Shorter Telomeres in Older South Australian Women. J. Nutr. Health Aging 2014, 18, 131–136. [Google Scholar] [CrossRef]
  80. Akbar, A.N.; Vukmanovic-Stejic, M. Telomerase in T Lymphocytes: Use It and Lose It? J. Immunol. 2007, 178, 6689–6694. [Google Scholar] [CrossRef] [Green Version]
  81. Weng, N.P.; Hathcock, K.S.; Hodes, R.J. Regulation of Telomere Length and Telomerase in T and B Cells: A Mechanism for Maintaining Replicative Potential. Immunity 1998, 9, 151–157. [Google Scholar] [CrossRef] [Green Version]
  82. Patrick, M.; Weng, N.-P. Expression and Regulation of Telomerase in Human T Cell Differentiation, Activation, Aging and Diseases. Cell Immunol. 2019, 345, 103989. [Google Scholar] [CrossRef] [PubMed]
  83. Schumacher, B.; Garinis, G.A.; Hoeijmakers, J.H.J. Age to Survive: DNA Damage and Aging. Trends Genet. 2008, 24, 77–85. [Google Scholar] [CrossRef]
  84. Li, J.S.Z.; Miralles Fusté, J.; Simavorian, T.; Bartocci, C.; Tsai, J.; Karlseder, J.; Lazzerini Denchi, E. TZAP: A Telomere-Associated Protein Involved in Telomere Length Control. Science 2017, 355, 638–641. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Sarek, G.; Kotsantis, P.; Ruis, P.; Van Ly, D.; Margalef, P.; Borel, V.; Zheng, X.-F.; Flynn, H.R.; Snijders, A.P.; Chowdhury, D.; et al. CDK Phosphorylation of TRF2 Controls T-Loop Dynamics during the Cell Cycle. Nature 2019, 575, 523–527. [Google Scholar] [CrossRef] [PubMed]
  86. Wojtyla, A.; Gladych, M.; Rubis, B. Human Telomerase Activity Regulation. Mol. Biol. Rep. 2011, 38, 3339–3349. [Google Scholar] [CrossRef] [Green Version]
  87. Walker, J.R.; Zhu, X.-D. Post-Translational Modifications of TRF1 and TRF2 and Their Roles in Telomere Maintenance. Mech Ageing Dev. 2012, 133, 421–434. [Google Scholar] [CrossRef] [PubMed]
  88. Shin, W.H.; Chung, K.C. Human Telomerase Reverse Transcriptase Positively Regulates Mitophagy by Inhibiting the Processing and Cytoplasmic Release of Mitochondrial PINK1. Cell Death Dis. 2020, 11, 425. [Google Scholar] [CrossRef]
  89. Milon, L.; Meyer, P.; Chiadmi, M.; Munier, A.; Johansson, M.; Karlsson, A.; Lascu, I.; Capeau, J.; Janin, J.; Lacombe, M.L. The Human Nm23-H4 Gene Product Is a Mitochondrial Nucleoside Diphosphate Kinase. J. Biol. Chem. 2000, 275, 14264–14272. [Google Scholar] [CrossRef] [Green Version]
  90. Saretzki, G. Extra-Telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress. Curr. Pharm. Des. 2014, 20, 6386–6403. [Google Scholar] [CrossRef]
  91. Chiodi, I.; Mondello, C. Telomere-Independent Functions of Telomerase in Nuclei, Cytoplasm, and Mitochondria. Front. Oncol. 2012, 2, 133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Mukherjee, A.K.; Sharma, S.; Sengupta, S.; Saha, D.; Kumar, P.; Hussain, T.; Srivastava, V.; Roy, S.D.; Shay, J.W.; Chowdhury, S. Telomere Length-Dependent Transcription and Epigenetic Modifications in Promoters Remote from Telomere Ends. PLoS Genet. 2018, 14, e1007782. [Google Scholar] [CrossRef] [PubMed]
  93. Mukherjee, A.K.; Sharma, S.; Bagri, S.; Kutum, R.; Kumar, P.; Hussain, A.; Singh, P.; Saha, D.; Kar, A.; Dash, D.; et al. Telomere Repeat–Binding Factor 2 Binds Extensively to Extra-Telomeric G-Quadruplexes and Regulates the Epigenetic Status of Several Gene Promoters. J. Biol. Chem. 2019, 294, 17709–17722. [Google Scholar] [CrossRef] [Green Version]
  94. Pedroso, I.M.; Hayward, W.; Fletcher, T.M. The Effect of the TRF2 N-Terminal and TRFH Regions on Telomeric G-Quadruplex Structures. Nucleic Acids Res. 2009, 37, 1541–1554. [Google Scholar] [CrossRef] [Green Version]
  95. Biffi, G.; Tannahill, D.; Balasubramanian, S. An Intramolecular G-Quadruplex Structure Is Required for Binding of Telomeric Repeat-Containing RNA to the Telomeric Protein TRF2. J. Am. Chem. Soc. 2012, 134, 11974–11976. [Google Scholar] [CrossRef]
  96. Sharma, S.; Mukherjee, A.K.; Roy, S.S.; Bagri, S.; Lier, S.; Verma, M.; Sengupta, A.; Kumar, M.; Nesse, G.; Pandey, D.P.; et al. Human Telomerase Expression Is under Direct Transcriptional Control of the Telomere-Binding-Factor TRF2. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
  97. Wood, A.M.; Rendtlew Danielsen, J.M.; Lucas, C.A.; Rice, E.L.; Scalzo, D.; Shimi, T.; Goldman, R.D.; Smith, E.D.; Le Beau, M.M.; Kosak, S.T. TRF2 and Lamin A/C Interact to Facilitate the Functional Organization of Chromosome Ends. Nat. Commun. 2014, 5, 5467. [Google Scholar] [CrossRef] [Green Version]
  98. Smith, E.D.; Garza-Gongora, A.G.; MacQuarrie, K.L.; Kosak, S.T. Interstitial Telomeric Loops and Implications of the Interaction between TRF2 and Lamin A/C. Differentiation 2018, 102, 19–26. [Google Scholar] [CrossRef] [PubMed]
Ijms 22 03457 g001 550
Figure 1. NM23-H2 ChIP-seq reads are enriched for TTAGGG or CCCTAA repeats from the telomeres. Reproduced with permission from Kar et al., 2012 NAR [5].
Figure 1. NM23-H2 ChIP-seq reads are enriched for TTAGGG or CCCTAA repeats from the telomeres. Reproduced with permission from Kar et al., 2012 NAR [5].
Ijms 22 03457 g001
Ijms 22 03457 g002 550
Figure 2. Dual regulation of human telomerase reverse transcriptase (hTERT) by NM23-H2: (A) NM23-H2 associates with the hTERT protein and represses the telomerase enzymatic activity [5]; (B) NM23-H2 directly binds the hTERT promoter and represses hTERT transcriptionally by recruiting REST/co-REST/LSD1/HDAC1/2 repressor complex on the hTERT promoter in a G-quadruplex dependent manner; (C) G-quadruplex binding ligands alter hTERT promoter epigenetics similar to G-quadruplex binding protein, NM23-H2 [12].
Figure 2. Dual regulation of human telomerase reverse transcriptase (hTERT) by NM23-H2: (A) NM23-H2 associates with the hTERT protein and represses the telomerase enzymatic activity [5]; (B) NM23-H2 directly binds the hTERT promoter and represses hTERT transcriptionally by recruiting REST/co-REST/LSD1/HDAC1/2 repressor complex on the hTERT promoter in a G-quadruplex dependent manner; (C) G-quadruplex binding ligands alter hTERT promoter epigenetics similar to G-quadruplex binding protein, NM23-H2 [12].
Ijms 22 03457 g002
Ijms 22 03457 g003 550
Figure 3. NM23-H2 could be mediating T cell activation by governing Ca2+ influx along with telomerase re-activation. (A) NM23-H2/NDPK-B phosphorylates KCa3.1 channel at Histidine 358 position, mediating T-cell activation [66], (B) Telomerase re-activation by depletion of NM23-H2 might induce hyper-proliferation of activated T cells [69,70,71,72].
Figure 3. NM23-H2 could be mediating T cell activation by governing Ca2+ influx along with telomerase re-activation. (A) NM23-H2/NDPK-B phosphorylates KCa3.1 channel at Histidine 358 position, mediating T-cell activation [66], (B) Telomerase re-activation by depletion of NM23-H2 might induce hyper-proliferation of activated T cells [69,70,71,72].
Ijms 22 03457 g003
Table
Table 1. Summary of telomere-associated and ageing-related observations of NM23/NDPK proteins.
Table 1. Summary of telomere-associated and ageing-related observations of NM23/NDPK proteins.
NM23 Protein Telomere Binding Interaction with Telomere Associated Protein Implication in Ageing and Cancer
NM23-H1 ✕
[6] 		✕
[6] 		√
[48,49,50,61,62]
NM23-H2 √
[5,6] 		√
[5,12,30,31,32] 		√
[12,61]
NM23-H4 -- [46,47]
NM23-H2 homolog, NM23B√
[7]		--
NM23-H5 homolog, NME5-like Cc √
[8]		--
✕: Studies report lack of interaction; √: Studies report interaction; -: No studies done in this respect.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sharma, S.; Sengupta, A.; Chowdhury, S. Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing. Int. J. Mol. Sci. 2021, 22, 3457. https://doi.org/10.3390/ijms22073457

AMA Style

Sharma S, Sengupta A, Chowdhury S. Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing. International Journal of Molecular Sciences. 2021; 22(7):3457. https://doi.org/10.3390/ijms22073457

Chicago/Turabian Style

Sharma, Shalu, Antara Sengupta, and Shantanu Chowdhury. 2021. "Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing" International Journal of Molecular Sciences 22, no. 7: 3457. https://doi.org/10.3390/ijms22073457

APA Style

Sharma, S., Sengupta, A., & Chowdhury, S. (2021). Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing. International Journal of Molecular Sciences, 22(7), 3457. https://doi.org/10.3390/ijms22073457

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop